Free Trial
→ Buffett’s favorite chart just hit 209% – here’s what that means for gold (From Golden Portfolio) (Ad) Buy BLRX Stock  Free BLRX Stock Alerts

BioLineRx (BLRX) Short Interest Ratio & Short Volume

BioLineRx logo
$3.40 -0.07 (-2.02%)
As of 12:11 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

BioLineRx Short Interest Data

BioLineRx (BLRX) has a short interest of 217,200 shares, representing 5.87% of the float (the number of shares available for trading by the public). This marks a -1.27% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.1, indicating that it would take 3.1 days of the average trading volume of 66,318 shares to cover all short positions.

Current Short Interest
217,200 shares
Previous Short Interest
220,000 shares
Change Vs. Previous Month
-1.27%
Dollar Volume Sold Short
$612,504.00
Short Interest Ratio
3.1 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
3,329,000 shares
Float Size
3,700,000 shares
Short Percent of Float
5.87%
Today's Trading Volume
7,259 shares
Average Trading Volume
66,318 shares
Today's Volume Vs. Average
11%
Short Selling BioLineRx?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for BioLineRx and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

BLRX Short Interest Over Time

BLRX Days to Cover Over Time

BLRX Percentage of Float Shorted Over Time

BioLineRx Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/2025217,200 shares $612,504.00 -1.3%5.9%3.1 $2.82
3/31/2025220,000 shares $651,200.00 +6.0%6.0%1.3 $2.96
3/15/2025207,500 shares $655,700.00 -9.5%5.6%1 $3.16
2/28/2025229,200 shares $767,820.00 +5.9%6.2%1.1 $3.35
2/15/2025216,400 shares $802,844.00 +76.1%5.9%1 $3.71
1/31/2025122,900 shares $437,524.00 -90.3%3.3%0.6 $3.56
1/15/20251,260,000 shares $5.27 million +53.3%N/A0.2 $4.18
12/31/2024822,200 shares $175,950.80 -0.7%N/A0.2 $0.21
12/15/2024827,800 shares $186,172.22 -10.2%N/A0.8 $0.22
11/30/2024921,900 shares $276,570.00 -16.2%N/A1.1 $0.30
11/15/20241,100,000 shares $523,160.00 +3.8%N/A1.6 $0.48
10/31/20241,060,000 shares $434,600.00 +70.6%N/A3.5 $0.41
10/15/2024621,400 shares $271,924.64 +351.3%N/A2.2 $0.44
9/30/2024137,700 shares $73,820.97 -23.2%N/A0.5 $0.54
9/15/2024179,200 shares $111,301.12 +28.7%N/A0.7 $0.62
8/31/2024139,200 shares $90,048.48 -47.9%N/A0.5 $0.65
8/15/2024267,200 shares $181,241.76 -3.3%N/A0.8 $0.68
7/31/2024276,400 shares $217,084.56 +130.9%N/A0.8 $0.79
7/15/2024119,700 shares $90,972.00 -63.1%N/A0.3 $0.76
6/30/2024324,300 shares $184,818.57 +52.9%N/A0.9 $0.57
6/15/2024212,100 shares $141,661.59 -40.5%N/A0.5 $0.67
5/31/2024356,200 shares $265,582.72 +62.6%N/A0.8 $0.75
5/15/2024219,100 shares $135,173.75 -46.6%N/A0.5 $0.62
4/30/2024410,600 shares $274,855.64 -47.6%N/A1 $0.67
4/15/2024783,600 shares $504,560.04 +32.5%N/A1.8 $0.64
3/31/2024591,500 shares $662,480.00 +82.2%N/A1.6 $1.12
3/15/2024324,700 shares $373,405.00 +76.6%N/A1 $1.15
2/29/2024183,900 shares $244,587.00 -8.1%N/A0.6 $1.33
2/15/2024200,000 shares $221,000.00 -19.7%N/A0.7 $1.11
1/31/2024249,100 shares $296,429.00 -4.7%N/A0.8 $1.19
1/15/2024261,500 shares $368,715.00 +16.1%N/A0.8 $1.41
12/31/2023225,200 shares $353,564.00 +96.2%N/A0.6 $1.57
12/15/2023114,800 shares $182,532.00 -59.2%N/A0.3 $1.59
11/30/2023281,100 shares $407,595.00 -21.3%N/A0.3 $1.45
11/15/2023357,300 shares $603,837.00 -27.2%N/A0.3 $1.69
10/31/2023490,600 shares $735,900.00 -52.4%N/A0.4 $1.50
10/15/20231,030,000 shares $1.65 million -59.8%N/A0.9 $1.60
9/30/20232,560,000 shares $4.66 million -42.7%N/A2.2 $1.82
9/15/20234,470,000 shares $8.72 million +86.3%N/A4.1 $1.95
8/31/20232,400,000 shares $4.20 million +2.6%N/A2.6 $1.75
Donald Trump is about to free crypto from its chains … (Ad)

Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election … surpassing $100,000 on Dec. 8 .… Now Juan believes it could hit $150,000 … or higher in 2025.

There's another coin he thinks could do even better.
8/15/20232,340,000 shares $3.49 million +9.9%N/A6.2 $1.49
7/31/20232,130,000 shares $3.28 million -14.8%N/A4.9 $1.54
7/15/20232,500,000 shares $4.18 million +8.2%N/A5.6 $1.67
6/30/20232,310,000 shares $3.68 million +0.9%N/A4.9 $1.60
6/15/20232,290,000 shares $4.05 million +19.3%N/A4.6 $1.77
5/31/20231,920,000 shares $3.02 million -1.5%N/A3.8 $1.58
5/15/20231,950,000 shares $2.69 million +69.6%N/A4 $1.38
4/30/20231,150,000 shares $1.23 million +21.3%N/A3.1 $1.07
4/15/2023948,300 shares $1.04 million +70.6%N/A2.8 $1.10
3/31/2023556,000 shares $492,894.00 +546.5%N/A1.8 $0.89
3/15/202386,000 shares $52,374.00 +9.7%N/A0.3 $0.61
2/28/202378,400 shares $46,648.00 -64.7%N/A0.3 $0.60
2/15/2023222,100 shares $137,702.00 +97.3%N/A0.9 $0.62
1/31/2023112,600 shares $70,926.74 -42.1%N/A0.3 $0.63
1/15/2023194,600 shares $134,488.06 +9.8%N/A0.6 $0.69
12/30/2022177,200 shares $104,548.00 +22.6%N/A0.5 $0.59
12/15/2022144,500 shares $92,248.80 -11.1%N/A0.4 $0.64
11/30/2022162,500 shares $114,546.25 -37.6%N/A0.4 $0.70
11/15/2022260,200 shares $176,936.00 +7.3%N/A0.7 $0.68
10/31/2022242,500 shares $205,446.00 +33.4%N/A0.9 $0.85
10/15/2022181,800 shares $152,712.00 +127.8%N/A0.7 $0.84
9/30/202279,800 shares $73,815.00 -80.5%N/A0.3 $0.93
9/15/2022408,300 shares $649,197.00 +17.3%N/A1.9 $1.59
8/31/2022348,200 shares $529,264.00 -20.7%N/A2.7 $1.52
8/15/2022439,000 shares $838,490.00 +14.3%N/A3.5 $1.91
7/31/2022384,000 shares $506,880.00 -6.6%N/A2.8 $1.32
7/15/2022411,200 shares $551,008.00 +14.8%N/A2.7 $1.34
6/30/2022358,100 shares $458,368.00 +3.7%N/A2.2 $1.28
6/15/2022345,400 shares $466,290.00 -18.1%N/A2 $1.35
5/31/2022421,800 shares $658,008.00 -11.7%N/A2.3 $1.56
5/15/2022477,400 shares $572,880.00 +30.8%N/A2.3 $1.20
4/30/2022365,000 shares $445,300.00 -9.5%N/A1.8 $1.22
4/15/2022403,300 shares $621,082.00 -20.8%N/A2 $1.54
3/31/2022509,200 shares $870,732.00 -11.3%N/A2.1 $1.71
3/15/2022574,100 shares $878,373.00 +14.7%N/A2 $1.53
2/28/2022500,700 shares $761,064.00 -6.1%N/A1.2 $1.52
2/15/2022533,400 shares $938,784.00 +25.9%N/A1.2 $1.76
1/31/2022423,800 shares $771,316.00 +6.5%N/A0.9 $1.82
1/15/2022398,100 shares $800,181.00 +21.4%N/A0.9 $2.01
12/31/2021328,000 shares $669,120.00 +19.5%N/A0.6 $2.04
12/15/2021274,600 shares $648,056.00 +135.3%N/A0.6 $2.36
11/30/2021116,700 shares $306,921.00 -36.8%N/A0.3 $2.63
11/15/2021184,500 shares $527,670.00 +18.0%N/A0.5 $2.86
10/29/2021156,400 shares $444,176.00 -54.1%N/A0.4 $2.84
10/15/2021340,700 shares $1.04 million +65.3%N/A0.8 $3.06
9/30/2021206,100 shares $566,775.00 +8.5%N/A0.4 $2.75
9/15/2021190,000 shares $513,000.00 -34.7%N/A0.2 $2.70
8/31/2021291,000 shares $835,170.00 +5.0%N/A0.3 $2.87
8/13/2021277,100 shares $836,842.00 +3.2%N/A0.3 $3.02
7/30/2021268,500 shares $867,255.00 +228.2%N/A0.2 $3.23
Watch This Robotics Demo Before July 23rd (Ad)

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."

Click here to watch the demo…
7/15/202181,800 shares $273,212.00 -27.2%N/A0 $3.34
6/30/2021112,300 shares $315,563.00 -64.8%N/A0 $2.81
6/15/2021319,100 shares $890,289.00 -50.7%N/A0.1 $2.79
5/28/2021647,600 shares $1.85 million +15.8%N/A0.1 $2.86
5/14/2021559,500 shares $1.59 million +27.6%N/A0.1 $2.85
4/30/2021438,500 shares $1.34 million +9.3%N/A0.1 $3.05
4/15/2021401,200 shares $1.10 million -3.0%N/A0.3 $2.73
3/31/2021413,400 shares $1.17 million -7.0%N/A0.2 $2.82
3/15/2021444,600 shares $1.35 million -34.2%N/A0.2 $3.03
2/26/2021675,400 shares $2.18 million -62.5%N/A0.3 $3.23
2/12/20211,800,000 shares $6.68 million +0.6%N/A0.7 $3.71
1/29/20211,790,000 shares $5.24 million -27.8%N/A0.7 $2.93
1/15/20212,480,000 shares $6.94 million +0.8%N/A0.4 $2.80
12/31/20202,460,000 shares $6.27 million -2.4%N/A0.4 $2.55
12/15/20202,520,000 shares $8.54 million +11.5%N/A0.5 $3.39
11/30/20202,260,000 shares $5.24 million -8.9%N/A0.5 $2.32
11/15/20202,480,000 shares $5.83 million +79.7%N/A0.5 $2.35
10/30/20201,380,000 shares $2.04 million -8.0%N/A0.3 $1.48
10/15/20201,500,000 shares $2.41 million No ChangeN/A6.1 $1.61
9/30/20201,500,000 shares $2.46 million -1.3%N/A4.5 $1.64
9/15/20201,520,000 shares $2.64 million -1.3%N/A4.2 $1.74
8/31/20201,540,000 shares $2.80 million -7.2%N/A3.5 $1.82
8/14/20201,660,000 shares $3.40 million +12.2%N/A2.3 $2.05
7/31/20201,480,000 shares $3.36 million +114.6%N/A2.1 $2.27
7/15/2020689,800 shares $1.22 million +60.2%N/A1.1 $1.77
6/30/2020430,600 shares $736,326.00 +7.3%N/A0.8 $1.71
6/15/2020401,200 shares $649,944.00 +432.8%N/A0.8 $1.62
5/29/202075,300 shares $146,082.00 +2.5%N/A0.2 $1.94
5/15/202073,500 shares $118,335.00 +25.6%N/A0.4 $1.61

BLRX Short Interest - Frequently Asked Questions

What is BioLineRx's current short interest?

Short interest is the volume of BioLineRx shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 217,200 shares of BLRX short. 5.87% of BioLineRx's shares are currently sold short. Learn More on BioLineRx's current short interest.

What is a good short interest ratio for BioLineRx?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BLRX shares currently have a short interest ratio of 3.0. Learn More on BioLineRx's short interest ratio.

Which institutional investors are shorting BioLineRx?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BioLineRx: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for BioLineRx?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.87% of BioLineRx's floating shares are currently sold short.

Is BioLineRx's short interest increasing or decreasing?

BioLineRx saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 217,200 shares, a drop of 1.3% from the previous total of 220,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is BioLineRx's float size?

BioLineRx currently has issued a total of 3,329,000 shares. Some of BioLineRx's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BioLineRx currently has a public float of 3,700,000 shares.

How does BioLineRx's short interest compare to its competitors?

5.87% of BioLineRx's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to BioLineRx: bluebird bio, Inc. (5.24%), Coeptis Therapeutics Holdings, Inc. (1.22%), Dyadic International, Inc. (0.56%), Shattuck Labs, Inc. (4.14%), Werewolf Therapeutics, Inc. (6.82%), LAVA Therapeutics (0.88%), Celularity Inc. (12.53%), Atara Biotherapeutics, Inc. (17.61%), SCYNEXIS, Inc. (1.88%), Iterum Therapeutics plc (3.67%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short BioLineRx stock?

Short selling BLRX is an investing strategy that aims to generate trading profit from BioLineRx as its price is falling. BLRX shares are trading up $0.25 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against BioLineRx?

A short squeeze for BioLineRx occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BLRX, which in turn drives the price of the stock up even further.

How often is BioLineRx's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLRX, twice per month. The most recent reporting period available is April, 15 2025.



Related Companies
Short Interest Tools

This page (NASDAQ:BLRX) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners
How to invest in Elon Musk’s Optimus before its launch
Elon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...
InvestorPlace | Sponsored
Elon Set to Shock the World by May 1st ?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...
Brownstone Research | Sponsored
This Is How Empires Fall
The headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...
Investors Alley | Sponsored
Is he more powerful than Trump?
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...
Porter & Company | Sponsored
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...
Colonial Metals | Sponsored
Trump and Buffett Are Quietly Leading America’s Gold Revival
The “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...
Golden Portfolio | Sponsored
Elon Musk’s next move from the Oval Office?
No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...
Weiss Ratings | Sponsored
This isn’t a trade war. It’s worse…
Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...
Stansberry Research | Sponsored